Prognostic Role of Tumor Mutational Burden in Cancer Patients Treated With Immune Checkpoint Inhibitors: A Systematic Review and Meta-Analysis | Synapse
July 29, 2021Open Access
Prognostic Role of Tumor Mutational Burden in Cancer Patients Treated With Immune Checkpoint Inhibitors: A Systematic Review and Meta-Analysis
Key Points
Key points are not available for this paper at this time.
Abstract
https://www.crd.york.ac.uk/PROSPERO, Prospective Register of Systematic Reviews (PROSPERO), identifier: CRD42021229016.